Back to news overview

Spin-off eTheRNA opens new lab

In the new lab in Niel, the company will be able to create its own m(essenger)RNA as part of the immunotherapy which is developed to fight skin cancer. Etherna has also appointed a new CEO: Steve Powell. 

Read more on De Tijd and VUB Today.